Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 25Leukemia, Lymphocytic, Chronic, B-Cell 10Breast Neoplasms 10Recurrence 9Leukemia, Myeloid, Acute 9Carcinoma, Non-Small-Cell Lung 9Neuroblastoma 8Lymphoma, Non-Hodgkin 8Neoplasms 7Ovarian Neoplasms 6Neoplasm Metastasis 6Leukemia 6Colorectal Neoplasms 6Carcinoma, Renal Cell 6Uveal Melanoma 5Myelodysplastic Syndromes 5Multiple Myeloma 5Lymphoma, Follicular 5Lymphoma 5Lung Neoplasms 5Head and Neck Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma, B-Cell 4Hematologic Neoplasms 4Carcinoma, Squamous Cell 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3

Interventions

Nivolumab 3osimertinib 2Pemetrexed 2Cetuximab 2Carboplatin 2spartalizumab 1napabucasin 1guadecitabine 1gallium 68 PSMA-11 1ficlatuzumab 1exemestane 1entinostat 1dostarlimab 1darolutamide 1apalutamide 1abexinostat 1Tyrosine Kinase Inhibitors 1Ramucirumab 1Radiosurgery 1Paclitaxel 1Leucovorin 1Irinotecan 1Interleukin-2 1Indocyanine Green 1HuMax-IL8 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Fulvestrant 1Fluorouracil 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms by Site × Interleukin-2 × Clear all
NCT01081808 2015-03-25

Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors

Roger Williams Medical Center

Phase 1 Terminated
2 enrolled

Carcinoma, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡